Northbound Flows Monthly: $21bn Inflows in January
We analyzed the Shanghai/Shenzhen Connect Scheme for January and highlight flows for CATL, Moutai, Ping An Insurance, Longi Green, Wuliangye.
603 Views
Anke Biotechnology (300009CH) Vs Changchun High & New Tech (000661CH)-Growth Hormone VBP and Outlook
We analyzed the impact and outlook of growth hormone VBP that led to share price plunge of Anke and CCHT. We also analyzed the bidding strategy for...
419 Views
Changchun High & New Tech (000661.CH) - Logic Change?
The article analyzed Changchun High & New Tech in terms of its 2021/1H financial results,media exposure of growth hormone abuse, possibility of...
336 Views
I-Mab (IMAB US) - Insights On Core Products TJC4, TJ202 and TJ101
As I-MAB has come to a key phase from R&D to commercialization, this article analyzed both the strength and the concerns for its core products...
390 Views
Shanghai Henlius Biotech IPO Initiation: Going Large
Shanghai Henlius Biotech (1566213D HK) is a biopharmaceutical company and a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group)...
891 Views